Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation.
Nephrology Nursing Journal Editorial Board Statements of Disclosure:
In accordance with ANCC governing rules Nephrology Nursing Journal Editorial Board statements of disclosure are published with each CNE offering. The statements of disclosure for this offering are published below.
Paula Dutka MSN, RN, CNN, disclosed that she is a coordinator of Clinical Trials for the following sponsors: Amgen, Rockwell Medical, Keryx Biopharmaceuticals, Akebia Therapeutics, and Dynavax Technologies.
Norma J. Gomez, MBA, MSN, CNNe, disclosed that she is a member of the ZS Pharma Advisory Council.
Carol M. Headley DNSc, ACNP-BC, RN, CNN, disclosed that she is a Consultant and/or member of the Corporate Speaker’s Bureau for Sanofi Renal, and a member of the Advisory Board for Amgen.
Tamara M. Kear, PhD, RN, CNS, CNN, disclosed that she is a Fresenius employee, and freelance editor for Lippincott, Williams & Wilkins and Elsevier publishing companies.
All other members of the Editorial Board had no actual or potential conflict of interest in relation to this continuing nursing education activity.
There are no other disclosures to declare.
This article was reviewed and formatted for contact hour credit by Beth Ulrich, EdD, RN, FACHE, FAAN, Nephrology Nursing Journal Editor, and Sally Russell, MN, CMSRN, CPP ANNA Education Director.
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
American Nephrology Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center Commission on Accreditation.
ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.
This CNE article meets the Nephrology Nursing Certification Commission’s (NNCC’s) continuing nursing education requirements for certification and recertification.
Learning Outcome: After completing this learning activity, the learner will be able to recognize the temporal patterns of fatigue in patients on hemodialysis.
You must be logged in and own this product in order to
11/18/16 4:08 pm
A lot of dialysis patients are experiencing symptoms of fatigue after dialysis. I am working as a dialysis nurse in acute unit for 7 years. I would say that part of the problem is definitely fluid and hormone shifts after dialysis. Another part I think is excessive fluid removal. We have only one orienteer when we are setting goal for fluid removal that is estimated dry weight(EDW).Based on EDW we are programming dialysis machines and watching only two parameters: heart rate and blood pressure during Hemodialysis. EDW is guessing by nephrologist where patients should be at their baseline. When we were using Krit line, made by Fresenius, we had better orienteers based on hemoglobin level and oxygen saturation. From my own experience, I would say that by using this equipment we where able to individualize dialysis treatments. We had less code situations, our patients were less tired after dialysis. Unfortunately company recalled this product.